Quick Answer
USANA HEALTH SCIENCES INC reported Diluted EPS of $0.58 per share for fiscal year 2025.
USANA HEALTH SCIENCES INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.58 | -73.5% |
| 2024 | $2.19 | -33.6% |
| 2023 | $3.30 | -8.1% |
| 2022 | $3.59 | -37.3% |
| 2021 | $5.73 | -2.2% |
| 2020 | $5.86 | +32.9% |
| 2019 | $4.41 | -13.9% |
| 2018 | $5.12 | +102.4% |
| 2017 | $2.53 | -36.6% |
| 2016 | $3.99 | +11.1% |
| 2015 | $3.59 | +28.2% |
| 2014 | $2.80 | -49.6% |
| 2013 | $5.56 | +24.9% |
| 2012 | $4.45 | +36.5% |
| 2011 | $3.26 | +14.0% |
| 2010 | $2.86 | +31.8% |
| 2009 | $2.17 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.36 | -164.3% | -169.2% |
| June 30, 2025 | $0.52 | -3.7% | +6.1% |
| March 31, 2025 | $0.49 | -43.0% | -12.5% |
| September 30, 2024 | $0.56 | -5.1% | +3.7% |
| June 30, 2024 | $0.54 | -39.3% | -37.2% |
| March 31, 2024 | $0.86 | -9.5% | +45.8% |
| September 30, 2023 | $0.59 | -24.4% | -33.7% |
| June 30, 2023 | $0.89 | -11.0% | -6.3% |
- USANA HEALTH SCIENCES INC showed a decrease of -73.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, USANA HEALTH SCIENCES INC’s diluted eps has declined by 73.3% (from $2.17 per share to $0.58 per share).
- The most recent figure is from USANA HEALTH SCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: